Redhill Biopharma Ltd (NASDAQ:RDHL)

10.06
BATS BZX Real-Time Price
As of 10:42am ET
 +0.02 / +0.20%
Today’s Change
3.26
Today|||52-Week Range
11.35
+65.73%
Year-to-Date
RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib
Sep 23 / Zacks.com - Paid Partner Content
RedHill's opaganib shows encouraging action against SARS-CoV-2 in preclinical study, shares up 12%
Sep 08 / Seeking Alpha - Paid Partner Content
RedHill Biopharma (RDHL) Investor Presentation - Slideshow
Sep 11 / Seeking Alpha - Paid Partner Content
RedHill Biopharma (RDHL) Investor Presentation - Slideshow
Sep 04 / Seeking Alpha - Paid Partner Content
RedHill: Possibilities Abound
Sep 11 / Seeking Alpha - Paid Partner Content
State of Pennsylvania grants RedHill's opaganib COVID-19 grant
Sep 03 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close10.04
Today’s open9.95
Day’s range9.95 - 10.06
Volume900
Average volume (3 months)379,082
Market cap$372.2M
Data as of 10:42am ET, 09/29/2020

Growth & Valuation

Earnings growth (last year)+14.59%
Earnings growth (this year)+18.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.26%
P/E ratioNM
Price/Sales28.56
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...+0.12+2.04%
IDYAIDEAYA Biosciences I...-0.89-7.26%
STROSutro Biopharma Inc-0.05-0.49%
BDSIBioDelivery Sciences...-0.05-1.46%
Data as of 11:11am ET, 09/29/2020

Financials

Next reporting dateNovember 16, 2020
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$6.3M
Annual profit (last year)-$42.4M
Net profit margin-672.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts